Works about EUROPEAN Medicines Agency
Results: 1619
Prasugrel vs. Ticagrelor in acute coronary syndromes: Which one to choose?
- Published in:
- Wiener Klinische Wochenschrift, 2011, v. 123, n. 15/16, p. 468, doi. 10.1007/s00508-011-0027-7
- By:
- Publication type:
- Article
Access to medicines in the United Kingdom: a document analysis regarding health technology assessment recommendations for innovative medicines (2017–2020).
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 417, doi. 10.1007/s40267-024-01100-w
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Authorization of Vaccines in the European Union.
- Published in:
- Molecular Frontiers Journal, 2021, v. 5, n. 1/2, p. 58, doi. 10.1142/S2529732521400034
- By:
- Publication type:
- Article
Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity.
- Published in:
- Drug Metabolism Reviews, 2021, v. 53, n. 3, p. 375, doi. 10.1080/03602532.2021.1917599
- By:
- Publication type:
- Article
Identification of Medicinal Products: A Master Data Management Initiative.
- Published in:
- TechnoPharm, 2019, v. 9, n. 4, p. 1057
- By:
- Publication type:
- Article
Ce este important să știm despre boala meningococică și prevenirea ei.
- Published in:
- Medic.ro, 2022, v. 145, n. 1, p. 22
- By:
- Publication type:
- Article
Actualităţi COVID-19: vaccinare și efecte la distanţă.
- Published in:
- Medic.ro, 2023, v. 152, n. 2, p. 27, doi. 10.26416/Med.152.2.2023
- By:
- Publication type:
- Article
El monte nos cura Su biodiversidad nos aporta salud.
- Published in:
- Montes, 2023, n. 152, p. 52
- By:
- Publication type:
- Article
Pioglitazone: Balancing risks and benefits.
- Published in:
- Diabetes & Primary Care, 2011, v. 13, n. 4, p. 199
- By:
- Publication type:
- Article
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples.
- Published in:
- Analytical Letters, 2019, v. 52, n. 8, p. 1328, doi. 10.1080/00032719.2018.1537283
- By:
- Publication type:
- Article
Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017–2022.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2933, doi. 10.1007/s10072-023-06825-6
- By:
- Publication type:
- Article
Fingolimod as an effective therapeutic strategy for pediatric relapsing-remitting multiple sclerosis: two case reports.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis - a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Orphan drugs - comparative review of FDA and EMA regulations.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 133
- By:
- Publication type:
- Article
Toxicity of Antiretrovirals on the Sea Urchin Echinometra lucunter and Its Predicted Environmental Concentration in Seawater from Santos Bay (Brazilian Coastal Zone).
- Published in:
- Resources (2079-9276), 2021, v. 10, n. 11, p. 114, doi. 10.3390/resources10110114
- By:
- Publication type:
- Article
Rational use of inhaled corticosteroids for the treatment of COPD.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2023, v. 33, n. 1, p. 1, doi. 10.1038/s41533-023-00347-6
- By:
- Publication type:
- Article
Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2022.2147286
- By:
- Publication type:
- Article
Affordability of oncology drugs: accuracy of budget impact estimations.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2019.1697558
- By:
- Publication type:
- Article
Patient-reported outcome claims in European and United States orphan drug approvals.
- Published in:
- Journal of Market Access & Health Policy, 2018, v. 6, n. 1, p. 1, doi. 10.1080/20016689.2018.1542920
- By:
- Publication type:
- Article
International guidance on the selection of patient-reported outcome measures in clinical trials: a review.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 1, p. 21, doi. 10.1007/s11136-020-02625-z
- By:
- Publication type:
- Article
The rationale and practical issues for the maintenance of clean herds for clinical islet xenotransplantation.
- Published in:
- Xenotransplantation, 2008, v. 15, n. 2, p. 91, doi. 10.1111/j.1399-3089.2008.00458.x
- By:
- Publication type:
- Article
Treatment of Epidermolysis Bullosa and Future Directions: A Review.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2059, doi. 10.1007/s13555-024-01227-8
- By:
- Publication type:
- Article
Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2153, doi. 10.1007/s13555-024-01222-z
- By:
- Publication type:
- Article
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1273, doi. 10.1007/s13555-024-01170-8
- By:
- Publication type:
- Article
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 1917, doi. 10.1007/s13555-021-00612-x
- By:
- Publication type:
- Article
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 885, doi. 10.1007/s13555-021-00511-1
- By:
- Publication type:
- Article
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 2, p. 105, doi. 10.3390/brainsci10020105
- By:
- Publication type:
- Article
Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug Reactions.
- Published in:
- Brain Sciences (2076-3425), 2019, v. 9, n. 11, p. 322, doi. 10.3390/brainsci9110322
- By:
- Publication type:
- Article
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 1020, doi. 10.3390/biom11071020
- By:
- Publication type:
- Article
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 11, p. 668, doi. 10.3390/biom9110668
- By:
- Publication type:
- Article
News and Views: Update on technologies, medicines and treatments.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 7, p. 913, doi. 10.1111/dme.13965
- By:
- Publication type:
- Article
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 257, doi. 10.1111/hae.14944
- By:
- Publication type:
- Article
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 232, doi. 10.1111/hae.14912
- By:
- Publication type:
- Article
Registries and databases—A European perspective.
- Published in:
- Haemophilia, 2020, v. 26, p. 26, doi. 10.1111/hae.13920
- By:
- Publication type:
- Article
Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators.
- Published in:
- Haemophilia, 2015, v. 21, n. 4, p. 543, doi. 10.1111/hae.12634
- By:
- Publication type:
- Article
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.
- Published in:
- Haemophilia, 2012, v. 18, n. 4, p. 503, doi. 10.1111/j.1365-2516.2011.02685.x
- By:
- Publication type:
- Article
Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01087
- By:
- Publication type:
- Article
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01031
- By:
- Publication type:
- Article
Lavender (Lavandula angustifolia Mill.) Essential Oil Alleviates Neuropathic Pain in Mice With Spared Nerve Injury.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00472
- By:
- Publication type:
- Article
The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00398
- By:
- Publication type:
- Article
Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00169
- By:
- Publication type:
- Article
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies.
- Published in:
- Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00076
- By:
- Publication type:
- Article
Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development.
- Published in:
- Frontiers in Immunology, 2012, v. 3, p. 1, doi. 10.3389/fimmu.2012.00253
- By:
- Publication type:
- Article
Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
- Published in:
- Nature & Science of Sleep, 2021, v. 13, p. 75, doi. 10.2147/NSS.S245020
- By:
- Publication type:
- Article
Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 7, p. 922, doi. 10.1038/bmt.2012.270
- By:
- Publication type:
- Article
The Relationship between Animal Welfare and Antimicrobial Use in Italian Dairy Farms.
- Published in:
- Animals (2076-2615), 2021, v. 11, n. 9, p. 2575, doi. 10.3390/ani11092575
- By:
- Publication type:
- Article
The Use of Monensin for Ketosis Prevention in Dairy Cows during the Transition Period: A Systematic Review.
- Published in:
- Animals (2076-2615), 2021, v. 11, n. 7, p. 1988, doi. 10.3390/ani11071988
- By:
- Publication type:
- Article
Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.
- Published in:
- Animals (2076-2615), 2021, v. 11, n. 6, p. 1514, doi. 10.3390/ani11061514
- By:
- Publication type:
- Article
Antimicrobial Use in Broilers Reared at Different Stocking Densities: A Retrospective Study.
- Published in:
- Animals (2076-2615), 2020, v. 10, n. 10, p. 1751, doi. 10.3390/ani10101751
- By:
- Publication type:
- Article